Gene expression analysis is the determination of the gene pattern expressed at the level of gene transcription in a specific cell. It provides valuable information about the underlying molecular mechanisms that control gene expression. It helps to identify potential targets for therapeutic interventions. It finds widespread applications in cancer biology, developmental biology, pharmacology, and toxicology. It is also used in clinical settings for diagnostic and prognostic purposes. Several techniques are used for gene expression analysis, such as microarrays and RNA sequencing (RNA-seq).
The latest report by IMARC Group, titled “Gene Expression Analysis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” offers a comprehensive analysis of the industry, which comprises insights on the gene expression analysis market trends. The report also includes competitor and regional analysis, and contemporary advancements in the market.The global gene expression analysis market size reached US$ 4.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.2 Billion by 2028, exhibiting a growth rate (CAGR) of 9.2% during 2023-2028.
Request Free Sample Report: https://www.imarcgroup.com/gene-expression-analysis-market/requestsample
Global Gene Expression Analysis Market Demand:
The global market is primarily driven by the increasing prevalence of genetic disorders. In line with this, the advancements in genomic technologies, such as next-generation sequencing (NGS), are expected to significantly contribute to the market. Furthermore, the rising demand for personalized medicine is positively influencing the market. Apart from this, governments worldwide are heavily investing in research related to gene expression analysis to improve public health and develop new therapies.
Moreover, the rapid adoption of cloud-based services for gene expression analysis is creating a positive outlook for the market. Besides, the escalating usage of bioinformatics tools for analyzing gene expression data is propelling the market. Additionally, the rising focus on drug discovery and development is providing a boost to the market. Other factors driving the market include the increasing demand for biomarkers, the emergence of precision medicine, the growing demand for agricultural biotechnology, escalating demand for companion diagnostics, and the rapid adoption of gene therapy.
Competitive Landscape with Key Players:
- Agilent Technologies, Inc.
- BGI Genomics Co., Ltd.
- Bio-Rad Laboratories, Inc.
- Eurofins GSC Lux SARL
- Hoffmann-La Roche Ltd
- GE Healthcare
- Llumina, Inc.
- Oxford Gene Technology IP Limited
- Pacific Biosciences of California Inc.
- PerkinElmer Inc.
- QIAGEN GmbH
- Thermo Fisher Scientific Inc
Key Market Segmentation:
Products & Services:
- Polymerase Chain Reaction (PCR)
- Next Generation Sequencing (NGS)
- DNA Microarray
- Sanger Sequencing
- Low-to Mid-Plex Gene Expression Analysis
- High-Plex Gene Expression Analysis
- Pharmaceutical and Biotech Companies
- Academic Institutes and Research Centers
- North America Europe
- Asia Pacifi
- Latin America
- Middle East and Africa.
Key Highlights of the Report:
- Market Performance
- Market Outlook
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800